172@29@16@16!~!172@29@0@53!~!|company-article|alembic-pharmaceuticals|news|AP35!~!www|moneycontrol|com!~!|stocks|company_info|stock_news.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 22, 12:49
994.00
-3.05 (-0.31%)
VOLUME 14,225
LIVE
NSE
Oct 22, 12:49
993.00
-2.4 (-0.24%)
VOLUME 220,204
News on Alembic Pharmaceuticals
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Alembic Pharma gets USFDA nod for cholesterol lowering drug

11.59 am | 21 Oct 2020 |  Source: PTI

The approved product is therapeutically equivalent to the reference listed drug product Tricor Micronized Capsules of AbbVie Inc....

Alembic Pharmaceuticals gets USFDA nod for anti-viral drug

1.36 pm | 16 Oct 2020 |  Source: PTI

The approved product is therapeutically equivalent to the reference listed drug product Symmetrel tablets of Endo Pharmaceuticals, Inc....

Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater China

10.44 am | 13 Oct 2020 |  Source: PTI

According to a regulatory filing, Rhizen Pharmaceuticals is a Switzerland-based privately held clinical-stage biopharmaceutical company, and Curon Bio...

Alembic Pharma share price gains as associate company enters agreement to develop Tenalisib

10.32 am | 13 Oct 2020 |  Source: Moneycontrol.com

Rhizen Pharmaceuticals announced that it has entered into an exclusive license agreement with Curon Biopharmaceutical Limited. Alembic Pharmaceuticals...

Buy Alembic Pharma; target of Rs 1140: ICICI Direct

4.41 pm | 24 Jul 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated July 23,...

Buy Alembic Pharma; target of Rs 1180: YES Securities

7.08 pm | 23 Jul 2020 |  Source: Moneycontrol.com

YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated July 2...

Neutral Alembic Pharma; target of Rs 1122: Motilal Oswal

7.03 pm | 23 Jul 2020 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1122 in its research report dated July 22, 2020....

Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y

9.31 am | 23 Jul 2020 |  Source: Moneycontrol.com

NULL...

Neutral Alembic Pharmaceuticals; target of Rs 975: Motilal Oswal

1.41 pm | 07 Jul 2020 |  Source: Moneycontrol.com

Motilal Oswal recommended Neutral rating on Alembic Pharmaceuticals with a target price of Rs 975 in its research report dated July 05, 2020....

Buy Alembic Pharma; target of Rs 1100: YES Securities

6.48 pm | 23 Jun 2020 |  Source: Moneycontrol.com

YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 1...

Alembic Pharma Q4 profit jumps 81% to Rs 225 crore, FY20 net grows 42%

4.01 pm | 22 May 2020 |  Source: Moneycontrol.com

The company's revenue increased 30.2 percent to Rs 1,207 crore compared to the corresponding period last fiscal....

Buy Alembic Pharma; target of Rs 1100: YES Securities

4.24 pm | 20 May 2020 |  Source: Moneycontrol.com

YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 19...

Alembic Pharma Consolidated March 2020 Net Sales at Rs 1,206.83 crore, up 30.19% Y-o-Y

11.33 am | 28 Apr 2020 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Alembic Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.